Glucose-conjugated glutenin nanoparticles for selective targeting and delivery of camptothecin into breast cancer cells.

[1]  D. Koundal,et al.  Global Increase in Breast Cancer Incidence: Risk Factors and Preventive Measures , 2022, BioMed research international.

[2]  K. Yadav,et al.  Breast cancer in India: Present scenario and the challenges ahead , 2022, World journal of clinical oncology.

[3]  T. Gathani,et al.  Understanding breast cancer as a global health concern , 2021, The British journal of radiology.

[4]  Z. Shariatinia Big family of nano- and microscale drug delivery systems ranging from inorganic materials to polymeric and stimuli-responsive carriers as well as drug-conjugates , 2021 .

[5]  A. Krześlak,et al.  Contemporary Perspectives on the Warburg Effect Inhibition in Cancer Therapy , 2021, Cancer control : journal of the Moffitt Cancer Center.

[6]  Akshay Joshi,et al.  Polymeric Micelles Coated with Hybrid Nanovesicles Enhance the Therapeutic Potential of the Reversible Topoisomerase Inhibitor Camptothecin in a Mouse Model. , 2020, Acta biomaterialia.

[7]  Nicholas A. Peppas,et al.  Engineering precision nanoparticles for drug delivery , 2020, Nature reviews. Drug discovery.

[8]  M. Pedraza-Escalona,et al.  Glycosylated Nanoparticles for Cancer-Targeted Drug Delivery , 2020, Frontiers in Oncology.

[9]  A. Qattan Novel miRNA Targets and Therapies in the Triple-Negative Breast Cancer Microenvironment: An Emerging Hope for a Challenging Disease , 2020, International journal of molecular sciences.

[10]  S. Govindaraj,et al.  Surface receptor‐mediated targeted drug delivery systems for enhanced cancer treatment: A state‐of‐the‐art review , 2020, Drug development research.

[11]  Sureshbabu Ram Kumar Pandian,et al.  Formulation and evaluation of rutin-loaded solid lipid nanoparticles for the treatment of brain tumor , 2020, Naunyn-Schmiedeberg's Archives of Pharmacology.

[12]  Zehuan Liao,et al.  Smart nanocarriers for cancer treatment: Clinical impact and safety , 2020 .

[13]  Mohammed M Mehanna,et al.  Updated but not outdated "Gliadin": A plant protein in advanced pharmaceutical nanotechnologies. , 2020, International journal of pharmaceutics.

[14]  M. Sharifi-Rad,et al.  Lifestyle, Oxidative Stress, and Antioxidants: Back and Forth in the Pathophysiology of Chronic Diseases , 2020, Frontiers in Physiology.

[15]  A. Fazeli,et al.  Zeta Potential of Extracellular Vesicles: Toward Understanding the Attributes that Determine Colloidal Stability , 2020, ACS omega.

[16]  M. Arumugam,et al.  Bioactive and thermostable sulphated polysaccharide from Sargassum swartzii with drug delivery applications. , 2020, International journal of biological macromolecules.

[17]  Sureshbabu Ram Kumar Pandian,et al.  Formulation and characterization of folate receptor-targeted PEGylated liposome encapsulating bioactive compounds from Kappaphycus alvarezii for cancer therapy , 2020, 3 Biotech.

[18]  B. Salehi,et al.  Plant-Derived Bioactives and Oxidative Stress-Related Disorders: A Key Trend towards Healthy Aging and Longevity Promotion , 2020, Applied Sciences.

[19]  S. Jacob,et al.  Emerging role of nanosuspensions in drug delivery systems , 2020, Biomaterials Research.

[20]  P. Ranjekar,et al.  Phytochemicals in Cancer Treatment: From Preclinical Studies to Clinical Practice , 2020, Frontiers in Pharmacology.

[21]  S. Govindaraj,et al.  Design, in silico modelling and functionality theory of folate-receptor-targeted myricetin-loaded bovine serum albumin nanoparticle formulation for cancer treatment , 2019, Nanotechnology.

[22]  S. P. Srinivas,et al.  Current trends and challenges in cancer management and therapy using designer nanomaterials , 2019, Nano Convergence.

[23]  Chao Qiu,et al.  Preparation and characterization of redox-sensitive glutenin nanoparticles. , 2019, International journal of biological macromolecules.

[24]  Jingyan Tian,et al.  Nanoliposomal formulation encapsulating celecoxib and genistein inhibiting COX-2 pathway and Glut-1 receptors to prevent prostate cancer cell proliferation. , 2019, Cancer letters.

[25]  J. Natarajan,et al.  Modeling a pH-sensitive Zein-co-acrylic acid hybrid hydrogels loaded 5-fluorouracil and rutin for enhanced anticancer efficacy by oral delivery , 2019, 3 Biotech.

[26]  A. Misra,et al.  Combinatorial nanocarriers against drug resistance in hematological cancers: Opportunities and emerging strategies , 2019, Journal of controlled release : official journal of the Controlled Release Society.

[27]  Leonardo Fernandes Fraceto,et al.  Nano based drug delivery systems: recent developments and future prospects , 2018, Journal of Nanobiotechnology.

[28]  Z. Dai,et al.  Ultrasound Triggered Conversion of Porphyrin/Camptothecin-Fluoroxyuridine Triad Microbubbles into Nanoparticles Overcomes Multidrug Resistance in Colorectal Cancer. , 2018, ACS nano.

[29]  P. Mulvaney,et al.  Colloidal Stability of Apolar Nanoparticles: The Role of Particle Size and Ligand Shell Structure. , 2018, ACS nano.

[30]  Miryoung Kim,et al.  Daunorubicin and Cytarabine Liposome in Newly Diagnosed Therapy-Related Acute Myeloid Leukemia (AML) or AML With Myelodysplasia-Related Changes , 2018, The Annals of pharmacotherapy.

[31]  Samreen I. Ahmed,et al.  Principles of cancer treatment by chemotherapy , 2018, Surgery (Oxford).

[32]  A. Nel,et al.  Nanotechnology Strategies To Advance Outcomes in Clinical Cancer Care. , 2017, ACS nano.

[33]  Wei Zhang,et al.  Camptothecin-based nanodrug delivery systems , 2017, Cancer biology & medicine.

[34]  M. Akram,et al.  Awareness and current knowledge of breast cancer , 2017, Biological Research.

[35]  Quan Li,et al.  Shape dependent cytotoxicity of PLGA-PEG nanoparticles on human cells , 2017, Scientific Reports.

[36]  A. Elaissari,et al.  Protein-based nanoparticles: From preparation to encapsulation of active molecules. , 2017, International journal of pharmaceutics.

[37]  C. Bhattacharjee,et al.  Nanotechnology and nanocarrier-based approaches on treatment of degenerative diseases , 2017, International Nano Letters.

[38]  Jiang Yuan,et al.  Preparation and characterization of DOX loaded keratin nanoparticles for pH/GSH dual responsive release. , 2017, Materials science & engineering. C, Materials for biological applications.

[39]  K. Burgess,et al.  Small Molecules for Active Targeting in Cancer , 2016, Medicinal research reviews.

[40]  A. Otto Warburg effect(s)—a biographical sketch of Otto Warburg and his impacts on tumor metabolism , 2016, Cancer & metabolism.

[41]  N. Reddy,et al.  Development of wheat glutenin nanoparticles and their biodistribution in mice. , 2015, Journal of biomedical materials research. Part A.

[42]  R. Kaushik,et al.  Isolation, characterization of wheat gluten and its regeneration properties , 2015, Journal of Food Science and Technology.

[43]  Xiguang Chen,et al.  Glucose-conjugated chitosan nanoparticles for targeted drug delivery and their specific interaction with tumor cells , 2014, Frontiers of Materials Science.

[44]  K. Buschard,et al.  Dietary gluten and the development of type 1 diabetes , 2014, Diabetologia.

[45]  Xi-jun Wang,et al.  Plant-derived natural products as leads to antitumor drugs , 2014 .

[46]  B. Mishra,et al.  Mannose-conjugated chitosan nanoparticles loaded with rifampicin for the treatment of visceral leishmaniasis. , 2014, Carbohydrate polymers.

[47]  John C Kraft,et al.  Emerging research and clinical development trends of liposome and lipid nanoparticle drug delivery systems. , 2014, Journal of pharmaceutical sciences.

[48]  Baorui Liu,et al.  Facile preparation of paclitaxel loaded silk fibroin nanoparticles for enhanced antitumor efficacy by locoregional drug delivery. , 2013, ACS applied materials & interfaces.

[49]  J. Ramirez-Vick,et al.  Evaluation of the cytotoxic effect of camptothecin solid lipid nanoparticles on MCF7 cells , 2013, Drug delivery.

[50]  E. Mittendorf,et al.  Cancer immunotherapies, their safety and toxicity , 2013, Expert opinion on drug safety.

[51]  Radhakrishna Sureshkumar,et al.  Effects of nanoparticle charge and shape anisotropy on translocation through cell membranes. , 2012, Langmuir : the ACS journal of surfaces and colloids.

[52]  Anjan Nan,et al.  Combination Drug Delivery Approaches in Metastatic Breast Cancer , 2012, Journal of drug delivery.

[53]  Chandana Mohanty,et al.  Receptor mediated tumor targeting: an emerging approach for cancer therapy. , 2011, Current drug delivery.

[54]  V. Venditto,et al.  Cancer therapies utilizing the camptothecins: a review of the in vivo literature. , 2010, Molecular pharmaceutics.

[55]  M. Ozkan,et al.  A surface-charge study on cellular-uptake behavior of F3-peptide-conjugated iron oxide nanoparticles. , 2009, Small.

[56]  E. Miele,et al.  Albumin-bound formulation of paclitaxel (Abraxane® ABI-007) in the treatment of breast cancer , 2009, International journal of nanomedicine.

[57]  R. Wang,et al.  Functional properties of a new low-molecular-weight glutenin subunit gene from a bread wheat cultivar , 2006, Theoretical and Applied Genetics.

[58]  H. Klok,et al.  Advanced drug delivery devices via self-assembly of amphiphilic block copolymers. , 2001, Advanced drug delivery reviews.

[59]  H. M. Geller,et al.  Induction of neuronal apoptosis by camptothecin, an inhibitor of DNA topoisomerase-I: evidence for cell cycle-independent toxicity , 1996, The Journal of cell biology.

[60]  M. López-Meyer,et al.  Sites of accumulation of the antitumor alkaloid camptothecin in Camptotheca acuminata. , 1994, Planta medica.

[61]  A. Norin,et al.  A novel ligand in lymphocyte-mediated cytotoxicity: expression of the beta subunit of H+ transporting ATP synthase on the surface of tumor cell lines , 1994, The Journal of experimental medicine.

[62]  T. Burke,et al.  The structural basis of camptothecin interactions with human serum albumin: impact on drug stability. , 1994, Journal of medicinal chemistry.

[63]  O. Warburg,et al.  THE METABOLISM OF TUMORS IN THE BODY , 1927, The Journal of general physiology.